Clinical Research Directory
Browse clinical research sites, groups, and studies.
Proteinopathies Expression in Skin of Neurodegenerative Disorders
Sponsor: Universidad Autonoma de San Luis Potosí
Summary
The goal of this observational study is to compare the aggregation pattern of proteinopathies (alpha-synuclein, amyloid-beta, phosphorylated tau and transactive response DNA -binding protein 43 \[TDP43\]) in skin biopsies of patients with a neurodegenerative disease like Alzheimer's disease, frontotemporal lobe dementia, Parkinson's disease, atypical Parkinsonism, amyotrophic lateral sclerosis or normal pressure hydrocephalus. The main question it aims to answer is: * Is there a specific pattern of aggregation of proteinopathies in skin biopsies in each neurodegenerative disease in comparison to healthy control subjects? Skin biopsies will be analyzed using immunohistochemistry and immunofluorescence for detection of alpha-synuclein, amyloid-beta, phosphorylated tau and TAR DNA binding protein 43, and the aggregation patterns will be compared between patients with a neurodegenerative disease vs patient with normal pressure hydrocephalus vs healthy control subjects.
Official title: Expression of Proteinopathies in Skin Biopsies of Patients With Neurodegenerative Disorders
Key Details
Gender
All
Age Range
45 Years - Any
Study Type
OBSERVATIONAL
Enrollment
40
Start Date
2023-12-20
Completion Date
2026-11-01
Last Updated
2024-12-16
Healthy Volunteers
Yes
Conditions
Interventions
Immunohistochemistry and immunofluorescence
Skin biopsies will be analyzed using immunohistochemistry and immunofluorescence to detect the presence of aggregated a-synuclein, amyloid-b, p-TAU and TDP-43.
Locations (1)
Hospital Central Dr. Ignacio Morones Prieto
San Luis Potosí City, Mexico